Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022
23 Janeiro 2023 - 6:30PM
Conformis, Inc. (NASDAQ: CFMS), a leading medical device company
that features personalized knee and hip replacement products,
announced today it will release its financial results for the
fourth quarter and full-year ended December 31, 2022, after the
market closes on Wednesday, March 1, 2023.
Mark Augusti, CEO, and Bob Howe, CFO, will host
a webcast and conference call at 4:30 p.m. Eastern Time to discuss
the financial results and provide a business update.
Earnings Call and Webcast
Details:
The webcast of the earnings call will be live
at: Link Directly to Webcast
To attend by telephone, please use the
information below for dial-in access.
- Date and Time:
March 1, 2023 – 4:30 p.m. Eastern Time
- Please register
for the call. You can register any time starting now through the
call.
- Link to
register: Registration Link
- Registration in
advance is encouraged. As part of the registration
process, you can choose to be provided with the dial-in and PIN or
to use the automated “Call Me” feature.
Please visit the Investor Relations website at
ir.conformis.com on March 1, 2023, to view the earnings release
prior to the webcast and conference call.
The online archive of the webcast will be
available on the company’s website at ir.conformis.com for 30
days.
About Conformis, Inc.Founded in
2004, Conformis is a medical technology company focused on
advancing orthopedic patient care and creating a world without
joint pain. Its product portfolio is designed to maximize surgeon
and patient choice by offering fully personalized solutions through
its Image-to-Implant® Platinum Services℠ Program as well as
data-informed, standardized solutions that combine many benefits of
personalization with the convenience and flexibility of an
off-the-shelf system. Conformis’ sterile, just-in-time,
Surgery-in-a-Box™ delivery system is available with all of its
implants and personalized, single-use instruments. Conformis owns
or exclusively in-licenses issued patents and pending patent
applications that cover personalized implants and patient-specific
instrumentation for all major joints. For more information, visit
www.conformis.com. To receive future press releases via e-mail
alerts, sign up at ir.conformis.com.
ContactInvestor Contact:Investor
Relationsir@conformis.com(781) 374-5598
Conformis (NASDAQ:CFMS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Conformis (NASDAQ:CFMS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024